Latest Walter and Eliza Hall Institute of Medical Research Stories
Melbourne researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key ‘gatekeeper’ enzyme essential for malaria parasite survival.
Researchers from Melbourne's Walter and Eliza Hall Institute have discovered that breast stem cells and their 'daughters' have a much longer lifespan than previously thought, and are active in puberty and throughout life.
Melbourne researchers have identified a new way of protecting female fertility, offering hope to women whose fertility may be compromised by the side-effects of cancer therapy or by premature menopause.
A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease.
A gene network behind hardening of the arteries and coronary heart disease has been identified by a team of scientists from Australia, Europe and the United Kingdom.
MELBOURNE, Australia, Feb. 24 /PRNewswire/ -- The Board of the Walter and Eliza Hall Institute (WEHI) has announced that Professor Doug Hilton will be the Institute's next Director. Announcing Professor Hilton's appointment as Director-Designate, the President of the Board, Mr.
MELBOURNE, Australia, Oct. 27 /PRNewswire/ -- MuriGen Therapeutics today announced that its collaboration with CSL for the development of a new class of drugs that target arthritis and other inflammatory diseases has been restructured.
Plasmodium falciparum, the most lethal malaria parasite, is a housebreaking villain of the red blood cell world. Like a burglar searching for a way in to his targeted premises, the parasite explores a variety of potential entry points to invade the red blood cells of its human victims. When a weak point is found, the intrusion proceeds.
- A hairdresser.